HIPAA Security Rule risk analysis — beyond the template.
A defensible §164.308(a)(1)(ii)(A) risk analysis methodology with sampling, scoring and evidence.

This playbook captures the sequence MAST Consulting Group uses on HIPAA engagements when a programme owner has roughly the next two quarters to show measurable progress. It is opinionated, written to be lifted into your own plan, and assumes you already have a control framework in place — the question is how to move from documented to demonstrably operating.
Definition
The HIPAA Security Rule requires covered entities and business associates to conduct an accurate and thorough risk analysis (§164.308(a)(1)(ii)(A)) that identifies reasonably anticipated threats to ePHI confidentiality, integrity, and availability, assesses the likelihood and impact of each threat-vulnerability pair, and results in a documented risk register with risk levels. OCR's audit protocol and enforcement actions consistently cite inadequate risk analysis as the primary violation finding, making methodology defensibility critical.
Why it matters
The pressure on HIPAA programmes is shifting in specific, observable ways:
- OCR's 2023–2024 enforcement actions show that 78% of HIPAA settlements cited §164.308(a)(1)(ii)(A) risk analysis failure; average settlement amount was USD 1.2 million, with the highest (Montefiore Medical) reaching USD 4.75 million.
- HHS OCR's 2024 proposed Security Rule amendments would codify specific risk analysis content requirements — threat catalogue, asset inventory, control gap scoring — making ad hoc or template-only risk analyses legally insufficient.
- GCC hospitals with US payer contracts face contractual audit rights; a weak risk analysis is the first document requested in a payer compliance review and will trigger heightened scrutiny of all §164.308–§164.316 requirements.
- UAE's National Health Data and Information Centre (HDICC) is developing PHI governance rules that are expected to incorporate HIPAA risk analysis methodology; early adoption positions providers for dual compliance.
Evidence sources to capture
What an auditor or reviewer will sample for — wire each source into your evidence repository before the next review cycle:
- ePHI asset inventory — system name, data classification (ePHI type), custodian, location (on-prem/cloud), and last-verified date
- Threat-vulnerability pair register — threat ID, threat source, vulnerability description, §164.308–§164.312 control mapping, likelihood score (1–5), impact score (1–5), risk level (Low/Medium/High/Critical)
- Control effectiveness ratings — current control name, implementation status (implemented/partial/planned), effectiveness score (0–100%)
- Risk acceptance records — CISO/CRO signature, risk ID, residual risk level, acceptance rationale, and review date
- HHS SRA Tool export (XML or PDF) — auto-generated risk analysis report with all required §164.308(a)(1)(ii)(A) elements
Recommended next actions
A 90-day plan, sequenced so each step produces evidence the next step depends on:
- Day 0–30: ISMS Manager conducts ePHI asset discovery using the HHS SRA Tool supplemented by network scanning (Nmap, Nessus) and interviews with clinical department heads; produces a verified ePHI asset inventory.
- Day 31–60: Risk Analyst populates the threat-vulnerability matrix for each asset class (EHR systems, medical devices, cloud storage, email); scores likelihood and impact using a 5×5 matrix aligned with NIST SP 800-30.
- Day 61–90: IT Security implements priority remediation for all High/Critical risk pairs (target: ≥80% remediated or mitigated within 90 days); documents residual risk and CISO acceptance for remainder.
- Day 90+: Compliance Officer documents the completed risk analysis in the GRC platform (OneTrust or Archer); links each risk to §164.308–§164.312 control and schedules annual review.
- Ongoing: Update risk analysis within 30 days of any ePHI system change, new vendor onboarding, or breach event; conduct full annual refresh per §164.308(a)(1)(ii)(A).
Example metrics
Instrument these and report them monthly to the executive sponsor; sustained adverse trends become board-level conversations:
- ePHI asset inventory completeness — target 100% of ePHI-processing systems inventoried; zero undiscovered systems at OCR audit
- High/Critical risk pair remediation rate — target ≥80% remediated within 90 days of risk analysis completion
- Risk analysis refresh cycle — completed and CISO-approved within 12 months of prior analysis; triggered within 30 days of material system change
- Control effectiveness score (average across §164.308–§164.312) — target ≥75% effective rating across all required safeguards
- OCR audit-readiness score (using OCR audit protocol) — target ≥90% of risk analysis audit protocol items rated 'fully implemented'
A the next two quarters working plan
MAST Consulting Group runs this HIPAA work in four moves. Each move is short, evidence-producing, and signed off by a Lead Practitioner before the next begins.
- Frame (week 1). Confirm scope, regulators in play, and the decisions the work has to enable — referenced against the Privacy Rule (45 CFR Part 164 Subpart E). Without that framing, the rest becomes a documentation exercise the audit committee will not read.
- Diagnose (weeks 2–4). Walk through workforce training records and audit logs of ePHI access as they exist today. Capture not just gaps but the design decisions behind every existing control — those are usually where audit findings hide.
- Design (weeks 5–8). Make the contested choices early and pre-clear them with Department of Health (DoH Abu Dhabi) where ADHICS overlaps. Document the rationale; HIPAA reviewers care more about reasoned decisions than perfect ones.
- Operate (weeks 9–12). Move evidence collection into encrypted email gateways and MDM enforcing device encryption. A control that depends on a separate GRC tool nobody opens will fail within two cycles.
Pitfalls we keep seeing
Across MAST Consulting Group's HIPAA portfolio, the same recurring failure modes show up cycle after cycle. None are exotic; all are expensive when they reach the audit report.
- Pattern: training records that don't tie to the workforce roster on the date of the incident. What good looks like: the same control evidenced inside the workflow it governs, not separately for the audit.
- Pattern: risk analysis that lists assets but does not score threats and vulnerabilities. What good looks like: the same control evidenced inside the workflow it governs, not separately for the audit.
- Pattern: BAAs missing required clauses on subcontractor flow-down. What good looks like: the same control evidenced inside the workflow it governs, not separately for the audit.
- Pattern: ePHI on workforce laptops without device-level encryption evidence. What good looks like: the same control evidenced inside the workflow it governs, not separately for the audit.
Tooling we actually reach for
MAST Consulting Group is deliberately tool-agnostic, but in practice the same shortlist keeps appearing on HIPAA engagements because the integrations are cheap and the evidence is defensible:
- DLP tooling tuned for ePHI patterns — used not because it is fashionable, but because the audit trail it generates is one the reviewer accepts on the first ask.
- EHR audit log exports — used not because it is fashionable, but because the audit trail it generates is one the reviewer accepts on the first ask.
- encrypted email gateways — used not because it is fashionable, but because the audit trail it generates is one the reviewer accepts on the first ask.
How MAST Consulting Group can help
MAST Consulting Group runs HIPAA programmes for banks, insurers, healthcare networks, payments providers, telcos and government entities across the UAE, KSA, India and the wider GCC. We bring Lead Practitioners, sector specialists, and a working library of policies, risk methodologies and evidence templates that have passed audit at firms recognisable to your board.
If anything in this playbook is relevant to a programme you are scoping or rescuing, the fastest next step is a 30-minute working session with the practice lead. We will look at your specific situation, share what we have seen work for HIPAA programmes at similar scale, and tell you honestly if the work is something you should bring to us or run in-house.
Defensible HIPAA Security Rule risk analysis.
We help GCC providers and US-facing telehealth, BPO and clinical-trial firms run §164.308 risk analyses, BAAs and breach playbooks that withstand OCR scrutiny.
- §164.308(a)(1)(ii)(A) risk analysis methodology
- Business Associate Agreement review
- 72-hour breach notification runbook
Prefer email? info@mastcgroup.com
Talk to a HIPAA lead
Reply within one business day from a senior consultant.
Related insights
Matched on service area and shared topics.